Research and Enterprise Services What? Why? Who? Margaret Lawlor, Business Development Manager (BDM)

advertisement
Research and Enterprise Services
What? Why? Who?
Margaret Lawlor, Business Development Manager
(BDM)
margaret.lawlor@ncl.ac.uk
19th March 2012
Business Development
Directorate Restructuring
• BDD underwent a review in 2009
• Over the next 12 months a new structure was proposed
dispersing the central team into Faculty based teams
• Some new appointments
• Now , Academic & Commercial experience, Intellectual
Property (patent) Knowledge
• We are here to help!
Overview of Research & Enterprise
Services (RES)
Located centrally
Located
Within
Faculty
FMS
Enterprise
Team
RES Director
Douglas Robertson
SaGE
Enterprise
Team
Non traditional funding
KTP team
Legal team
Venture Unit
HaSS
Enterprise
Team
Enterprise Team in FMS
RES Director
Douglas
Robertson
Assistant Director
FMS Enterprise
Martin Cox
Institute facing BDM
NICR Phil Elstob
Institute facing BDM
Marie Labus
Institute facing BDM
Laura Rush
Institute facing BDM
Margaret Lawlor
Proposal and Project
Support Officer
Helen Kelt
Proposal and Project
Support Officer
Linda Wilson
Assistant Director
Changing Age
Graham Armitage
Project Oversight &
Engagement Officer
Pauline Davidson
Senior Clerical
Assistant
Ruth Pollard
Clerical
Assistant
Claire Forsythe
Changing
Age team
Clerical
Assistant
Dot Steel
What do we do?
• Provide support for all aspects of commercialisation
including:
• Funding/Translational grants
• Consultancy
• Commercial research
• Confidentiality Agreements
• Material Transfer Agreements
• Patents
• Licensing
• Company spin outs
We can help you find commercial partners
and we help setup agreements
Funding
• Joint Research Office, guidance on research
funding, contracts
http://www.ncl.ac.uk/researchfundingtoolkit/
• Translational Grants will require BDM input
Translational Grants
• Increasing number of funding bodies require
commercial partners:
• MRC: Development Pathway Funding Scheme, (MICA)
MRC industry collaboration award
• NIHR, invention for innovation (i4i)
• NIHR & Wellcome Health Innovation Challenge Fund
• Input of ‘technology transfer office’: business plan, due
diligence, etc.
• May require fairly rigorous project management – very
different to many other grants
• We can find you a commercial partner
Other Funding
• Knowledge Transfer Partnerships (KTPs)
• Shorter KTPs
University Fiona McCusker, fiona.mccusker@ncl.ac.uk
• Technology Strategy Board – need a commercial
partner.
• CASE studentships
Consultancy
• Easy, Nothing new
•
- Facilities
- Knowledge/Advice
- Teaching
• With external
- Company,
- Government Organisation,
- Funding body
• Your time is valuable, don’t undervalue!
• Confidentiality?
Personal Consultancy
• Should receive written permission from Head of
department
• Everything must be out-with university (time,
travel, expenses, liability insurance etc)
Commercial Research
• New Research
- New Intellectual
Property?
• Projects with
- Company
- Other External
partner (Uni, NHS)
• Your BDM can help find commercial
partners and put right agreements
in place
What to Consider
•
Confidentiality Agreement (CDA/NDA)
•
Material Transfer Agreement (MTA)
•
Intellectual Property Rights (IPR) Contract/Agreement
•
Always better to think about protecting your ideas before starting
work.
• If you need a CDA/MTA contact you Business Development Manager
(BDM) and we will help
RES Business Voucher Scheme
A business voucher for matched funding of up to £5,000
towards a wide range of Newcastle University services
including:
•
•
•
•
•
•
•
Consultancy services
Commercial research
Design
Facilities and room hire
Accredited training courses
Non-accredited training courses
Analytical and testing services
RES Commercial Relationships &
Collaboration Support
• Funding can be use towards
Travel
Attending or Hosting Events or Conferences
•
Academic, Researchers, Postgraduates
Confidentiality Agreement (CDA/NDA)
• What
- CDA/ NDA (non disclosure agreement)
• When
- With external Company/ Organisation
- Multi organisational grants
- External collaborators
- visiting students
• Why
- Protects Know How
- Protects Patentability
- Once an Idea is disclosed it cannot be
undone!
Material Transfer Agreement (MTA)
• Reagents
- Controls who uses your reagents (cell lines, Abs)
- Controls what is done with your reagents
“Cash in Freezer”
•
•
•
•
Antibodies
Cell lines
Mice
Other Reagents
• Don’t undervalue the
time and effort in
developing reagents
• Your BDM will find you
the right partner
Intellectual Property (IP)
• What is Intellectual Property?
- Know how, confidential information
- contacts (collaborators)/contracts, goodwill
- Trademarks
- Copyright and database rights
- Design Rights (registered and
unregistered)
- Patents
Belongs to University/Inventor
If you think you have some IP contact
your BDM and we can help
Patents 1
The first account of a "patent system"
•
In the ancient Greek city of Sybaris (destroyed in 510 BC), leaders
decreed:
•
"If a cook invents a delicious new dish, no other cook is to be
permitted to prepare that dish for one year.
•
During this time, only the inventor shall reap the commercial profits
from his dish. This will motivate others to work hard and compete in
such inventions."
Patents 2
Senate of Venice, 1474:
"Any person in this city who makes any new and ingenious
contrivance, not made heretofore in our dominion, shall, as
soon as it is perfected so that it can be used and exercised,
give notice of the same to our State Judicial Office, it being
forbidden up to 10 years for any other person in any
territory of ours to make a contrivance in the form and
resemblance thereof".
Today:
New to the world (Europe); up to 20 years of protection
Incentive to innovate
Incentive to share knowledge
(grant protection)
(publish the invention's details)
Patents 3
GB patent No. 1769-913: Watt's improved
steam engine
GB patent No. 1769-913: Watt's
improved steam engine
Patents 4
• Give strongest legal protection for Intellectual
Property for a defined period of time (20 years)in
defined territory eg country but expensive
• To patent the Idea must be Novel, Inventive and
Commercially applicable
• Must be enabling ie enough information for someone
else to repeat
• Cannot patent a hypothesis
• Your BDM can help you decide if you
have an invention and find partners
Much information only available in
patents
Published
elsewhere
Published
in patents
found only in patents!
Patents: University Process
• If you think you have an invention
contact your BDM and we will help
make the most of your idea
• Academic fills in IRQ/BOF with BDM’s help
• BDM will assess: Background (Freedom to Operate
& Prior Art), Market, Business partner
• Decision to file (University & Inventor)
Licensing (BDM)
•
•
•
•
Licensing useful revenue stream
Develop collaborations
Spreading development risk
Consider
- Type of IP being licensed (patent, software,
trademark)
- Licensor (company taking licence)
- Type of license (use, exclusive/non exclusive)
- Market value/practice
- Bargaining power (how strong is you IP)
- Agreement
Closed Versus Open Innovation
Closed Versus Open Innovation
Source Henry Chesbrough
Open Innovation = More Opportunities for Newcastle!!
Company spin-outs
• Not for everyone
• Old University model: Discovery - Patent - Spinout/licence/buy-out/market
• Collaboration at different stages
Drug Discovery Process
University
Discovery
(2-10 yrs)
0
2
Preclinical
testing
4
Phase II
Phase I
6
Phase III
8
10
Increase in commercial value
12
FDA
PostReview marketing
and
Testing
Approval
14
16yrs
Company spin-outs
• http://www.ncl.ac.uk/res/ventures/index.htm
A word about the Trust
• Very close relationships with Newcastle Upon
Tyne Hospitals
• Joint Business Executive
• Joint team
• Split all income
Any questions please contact
margaret.lawlor@ncl.ac.uk
Tel 0191 208 3369
Download